Keyphrases
Obesity
100%
Glycemic Index
89%
Type 2 Diabetes Mellitus (T2DM)
70%
Glycemic Response
67%
Insulin Resistance
65%
Diabetic
58%
Healthy Adults
56%
Stevia
53%
Sweeteners
47%
Hypertensive
47%
Type 1 Diabetes Mellitus (T1DM)
47%
Carbohydrates
46%
Glycemic Index and Glycemic Load
45%
Insulin
42%
Colombia
42%
Metabolic Syndrome
41%
Nutritional Supplements
40%
Computed Tomography
39%
Dice Score
37%
Positron Emission Tomography-computed Tomography (PET-CT)
37%
Base of the Pyramid
37%
Venezuela
37%
Health Spending
37%
Flax Fiber
37%
Pro-resolving Lipid Mediators
37%
Older Adults
37%
Insulin Response
37%
Socioeconomic Level
37%
Non-nutritive Sweeteners
35%
Dietary Fiber
33%
Postprandial Insulin
33%
Nutritional Status
32%
Glycemic Load
32%
Inflammation
28%
White Bread
26%
Healthy Individuals
26%
Sucralose
25%
Soluble Fiber
25%
Hypertension
24%
Schoolchildren
23%
Parameter Tuning
22%
End-diastole
22%
Bisphenol A
22%
Flaxseed
22%
Body Mass Index
22%
Cardiovascular Risk
22%
Gut Microbiota
22%
Type 2 Diabetic Patients
22%
Glycemic Efficacy
22%
Chile
21%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
46%
Sweetening Agent
37%
Metabolic Syndrome
37%
Disease
36%
Insulin Resistance
32%
Diabetes Mellitus
31%
Adolescent
26%
Positron Emission Tomography-Computed Tomography
25%
Diabetes
23%
Computer Assisted Tomography
22%
Prevalence
21%
Hyperglycemia
19%
Diagnostic Imaging
18%
Multidetector Computed Tomography
18%
Bisphenol A
18%
Glucagon
18%
Childhood Obesity
18%
Public Health
18%
Adipose Tissue
18%
Atherosclerosis
18%
Leptin
18%
Obesity
18%
Cardiovascular Disease
18%
Complications of Diabetes Mellitus
18%
Advanced Glycation End-Product
18%
Neoplasm
18%
Cardiovascular Risk
18%
Attention Deficit Disorder
18%
Mediator
18%
Degenerative Disease
18%
Central Nervous System
18%
FTO Gene
18%
Entero
18%
Nutrition Supplement
18%
Glycemic Index
18%
Palatinose
18%
Gut Microbiota
18%
Patient with Type 2 Diabetes
18%
Glucagon Release
12%
Endocrine Disruptor
12%
Water-Electrolyte Imbalance
12%
Epidemic
12%
Body Mass Index
12%
Glucagon Like Peptide 1
12%
Mild Cognitive Impairment
10%
Chronic Disease
10%
DNA Replication
9%
Cancer Growth
9%
Pediatrics
9%
Short Chain Fatty Acid
9%